Skip to Content

What is red baby syndrome?

Red baby syndrome is a rare condition that causes irritability and red staining of the skin in infants. It is associated with the antibiotic erythromycin. Here is a quick overview of red baby syndrome:

What causes red baby syndrome?

Red baby syndrome is caused by a buildup of erythromycin in the body. Erythromycin is a common antibiotic used to treat bacterial infections in infants. It is sometimes prescribed to treat ear infections, pneumonia, sinusitis, and other conditions. In some infants, erythromycin can build up in the body to toxic levels and cause red baby syndrome.

Who is at risk for red baby syndrome?

Red baby syndrome is rare, but infants are at a higher risk if they:

  • Are given high doses of erythromycin
  • Have liver dysfunction that impairs erythromycin breakdown
  • Have reduced kidney function that decreases erythromycin excretion
  • Are also taking certain other medications that interact with erythromycin

What are the symptoms of red baby syndrome?

The most noticeable symptom is a bright red discoloration of the skin. This rash can cover the entire body or be localized to certain areas. Other possible symptoms include:

  • Extreme irritability
  • Vomiting
  • Diarrhea
  • Poor feeding
  • Crying/screaming fits

Symptoms of red baby syndrome often begin within a few days of starting erythromycin treatment. However, the time frame can vary from hours to weeks after the first dose.

How is red baby syndrome diagnosed?

Doctors may suspect red baby syndrome based on the infant’s symptoms and recent use of erythromycin. However, testing is needed to confirm the diagnosis. This may include:

  • Blood tests to check erythromycin levels
  • Liver function tests
  • Kidney function tests
  • Testing for infections that could cause similar symptoms

If erythromycin levels are elevated and no other cause is found, the diagnosis is red baby syndrome.

How is red baby syndrome treated?

The main treatment is stopping erythromycin immediately. This allows the drug levels to start declining. Other treatment approaches include:

  • Intravenous (IV) fluids to prevent dehydration
  • Medications to control vomiting or diarrhea
  • Calming techniques to soothe irritability
  • Careful monitoring for secondary infections

With prompt treatment, infants with red baby syndrome usually recover within a few days after erythromycin is stopped. In more severe cases, hospitalization may be needed.

Can red baby syndrome be prevented?

Prevention focuses on cautious use of erythromycin in infants:

  • Carefully calculate dosing based on weight
  • Avoid use in preterm or jaundiced infants when possible
  • Monitor liver/kidney function if erythromycin is needed
  • Watch for signs of toxicity
  • Consider alternative antibiotics when appropriate

While erythromycin is sometimes the best treatment option, these precautions can help prevent red baby syndrome.

What is the long-term outlook for red baby syndrome?

If recognized and treated promptly, infants with red baby syndrome generally recover with no lasting effects. Very rarely, severe cases can lead to complications like hearing loss or brain toxicity. Overall, the prognosis is excellent in most cases. However, erythromycin should be avoided in any infant who has experienced red baby syndrome in the past.

Key Points About Red Baby Syndrome

  • Caused by buildup of erythromycin antibiotic in the body
  • Results in red skin rash, irritability, vomiting, and diarrhea
  • Rare condition seen in infants on erythromycin treatment
  • Resolves with prompt discontinuation of erythromycin
  • Preventable with careful dosing and monitoring of erythromycin
  • Excellent prognosis in most cases with no lasting effects

Conclusion

Red baby syndrome is a pediatric condition that parents and medical providers should be aware of when erythromycin is used to treat infections in infants. Careful dosing and monitoring can help prevent this rare but distressing reaction. Prompt recognition of the signs and discontinuation of erythromycin leads to excellent outcomes in the vast majority of cases. While erythromycin is an effective antibiotic, weighing the risks and benefits is important when prescribing it to vulnerable infants.